Are you concerned about additional safety issues with using topical ruxolitinib cream in patients treated with dupilumab or tralokinumab?
Featuring James Del Rosso, DO | Clinical Advisor |
Adjunct Clinical Professor, Dermatology
Touro University Nevada
Henderson, NV